International multi-center 64-slice CT trial enrolls 400 patients
Toshiba America Medical Systems, Inc. announced the enrollment of 400 patients in its CorE 64 (Coronary Evaluation on 64) study taking place across seven countries, evaluating the use of 64-slice CT technology.

Toshiba’s CorE 64 trial investigates the use of multi-slice CT as a diagnostic tool for detecting cardiovascular diseases and disorders, as compared to cardiac catheterization. Data collected to date from CorE 64 indicates CT as a diagnostic alternative to cardiac catheterization and has the potential to change the delivery of healthcare. 

“We expect CorE 64 findings to impact the overall reimbursement guidelines for multi-slice CT, resulting in greater patient access to these exams and to have significant economic benefits for 64-slice CT,” explained Toshihiro Rifu, senior fellow, Toshiba Medical Systems Corporation. 

The CorE 64 multi-center study participants include nine sites across seven countries:
  • Johns Hopkins University School of Medicine, in Baltimore, Md., led by primary investigators Drs. João A. C. Lima and Julie Miller;
  • Johns Hopkins Bayview Medical Center in Baltimore, Md.;
  • Beth Israel Deaconess Medical Center at Harvard in Boston, Mass.;
  • Leiden University Medical Center in the Netherlands;
  • Humboldt University, Campus Charité Mitte in Germany;
  • INCOR Heart Institute of the School of Medicine Hospital, Sao Paulo University in Brazil;
  • Iwate Medical University in Japan;
  • Mount Elizabeth Hospital in Singapore; and
  • Toronto General Hospital, University Health Network and Mount Sinai Hospital in Canada.
For more information about CorE 64, please visit